LBPH Live signals | Maximize Profits with Getagraph.com

BUY 113735 min ago

@ $20.40

Issued: 14 Feb 2024 @ 12:18

Return: 8.87%

Previous signal: Feb 13 - 15:23

Previous signal: Sell

Return: 0.94 %

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 12:53):

Stats
Today's Volume	126 588
Average Volume	523 030
Market Cap	799.94M
EPS	$-0.620 ( 2024-03-14 )
Next earnings date	( $-0.600 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9.29
ATR14	$0.0800 (0.36%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-08	Kaye Randall	Buy	107 560	Stock Option (Right to Buy)
2024-02-08	Kaye Randall	Buy	17 920	Common Stock
2024-02-08	Roberts Brandi	Buy	90 580	Stock Option (Right to Buy)
2024-02-08	Roberts Brandi	Buy	15 090	Common Stock
2024-02-08	Lind Kevin Robert	Buy	332 134	Stock Option (Right to Buy)

INSIDER POWER
-62.96
Last 48 transactions
Buy: 2 180 330 \| Sell: 4 964 362

Volume Correlation

Long: -0.08 (neutral)

Short: 0.30 (neutral)

Signal:(54.159) Neutral

Longboard Correlation

10 Most Positive Correlations
EYEG	0.911
APEN	0.902
MGYR	0.877
LITM	0.877
XOMAP	0.876
ANSS	0.865
CYTK	0.86
INBX	0.845
LMRK	0.836
IMRA	0.824

10 Most Negative Correlations
GOODM	-0.949
ALVR	-0.946
ADN	-0.871
RMRM	-0.847
MIST	-0.847
DWSH	-0.833
GNUS	-0.831
BXRX	-0.822
BJDX	-0.814
AADI	-0.809

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Longboard Correlation - Currency/Commodity

0.60
( weak )

0.69
( moderate )

0.00
( neutral )

0.13
( neutral )

0.30
( neutral )

-0.52
( weak negative )

Longboard Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-5 000.00 (0.00 %)
EPS:	$-2.39

FY	2023
Revenue:	$0
Gross Profit:	$-5 000.00 (0.00 %)
EPS:	$-2.39

FY	2022
Revenue:	$0
Gross Profit:	$-5 000.00 (0.00 %)
EPS:	$-2.51

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.648

Financial Reports:

No articles found.

Longboard

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.

Realtime updates for Longboard [LBPH]

Upcoming Earnings Alert